What protocol should a skilled nursing facility or long‑term care facility follow for patients receiving cough‑assist (mechanical insufflation‑exsufflation) and high‑frequency chest wall oscillation vest therapy?

Protocol for Cough Assist and Therapy Vest in SNF/LTC Facilities

SNF/LTC facilities should implement a structured protocol for mechanical insufflation-exsufflation (cough assist) and high-frequency chest wall oscillation (therapy vest) that prioritizes patient selection based on underlying diagnosis, establishes clear treatment parameters, monitors efficacy through objective measures, and includes safety checkpoints to prevent respiratory complications and reduce hospitalizations.

Patient Selection Criteria

Mechanical Insufflation-Exsufflation (Cough Assist) - Primary Indication

• Neuromuscular disease patients with impaired cough are the primary candidates 1
• Use when assisted peak cough flows decrease to <270 L/min 1
• Recommended to prevent respiratory complications in this population (Grade C recommendation) 1

Critical Contraindication

• Do NOT use manually or mechanically assisted cough in patients with COPD or airflow obstruction - this may be detrimental (Grade D recommendation) 1
• This is a crucial safety consideration that must be built into your protocol

High-Frequency Chest Wall Oscillation (Therapy Vest)

• Consider for cystic fibrosis patients as an alternative to conventional chest physiotherapy 1
• Evidence is conflicting for other populations (Grade I recommendation) 1
• May be used for patients with copious secretions and mucus hypersecretion 1

Treatment Parameters and Initiation

Cough Assist Device Settings

• Insufflation phase: Gradually inflate lungs above reduced vital capacity 2
• Exsufflation phase: Immediate abrupt change to negative pressure for 1-3 seconds 1
• Target: Increase peak cough expiratory flows (can increase by >4-fold with proper technique) 1

Individualized vs. Protocolized Approach

• Both approaches are acceptable based on clinician confidence and patient complexity 3
• For ventilator-dependent spinal cord injury patients, structured protocols have shown positive outcomes with low pneumonia rates 4

Efficacy Monitoring - Essential Components

Objective Measures to Track

1. MI-E-assisted cough peak flow (CPF) - primary measure 3
2. 24-hour sputum volume - should show reduction with effective therapy 5
3. Dyspnea scores (mMRC scale, Borg scale) 5
4. Respiratory rate and oxygen saturation
5. Frequency of respiratory complications 1

Do Not Rely Solely On:

• Spirometry changes (may not show short-term improvement) 5
• Inflammatory markers alone 5

Safety Protocol Requirements

Pre-Treatment Assessment

• Verify diagnosis (neuromuscular disease vs. COPD/obstructive disease)
• Assess respiratory muscle strength (maximum inspiratory pressure Z-score) 5
• Evaluate device tolerability before full implementation 5

Monitoring During Treatment

• No serious adverse events reported in studies, but monitor for:
  • Hemodynamic instability
  • Oxygen desaturation
  • Patient discomfort or intolerance 6
• Treatment is generally well-tolerated when properly applied 7, 5, 6

Red Flags for Discontinuation

• Development of airflow obstruction symptoms
• Hemodynamic instability
• Worsening respiratory status despite therapy

Frequency and Duration

Treatment Schedule

• Twice-daily sessions are commonly used 8
• Increase frequency during acute exacerbations or respiratory infections 1
• Continue long-term for neuromuscular patients, including home discharge 4

Expected Outcomes Timeline

• Sputum clearance improvement: Within 24 hours 5
• Dyspnea reduction: Within days 5
• Reduced hospitalization rates: Requires consistent protocol adherence over time 1

Staffing and Training Requirements

Essential Staff Competencies

• Knowledge of device operation and parameter adjustment 3, 9
• Ability to distinguish neuromuscular weakness from obstructive disease 1
• Skills in assessing cough peak flow 3
• Recognition of treatment failure or adverse effects

Interprofessional Involvement

• Respiratory therapists for device management
• Nursing staff for daily monitoring and documentation
• Physicians for patient selection and protocol oversight 9

Documentation Requirements

Each treatment session must document:

• Device settings used
• Sputum volume and characteristics
• Patient tolerance
• Vital signs pre/post treatment
• Any adverse events
• Efficacy measures (CPF when possible)

Integration with Other Therapies

Complementary Techniques

• Teach huffing as an adjunct (Grade C recommendation) 1
• Consider expiratory muscle training for neuromuscular patients (Grade E/C recommendation) 1
• Combine with appropriate positioning

Avoid Combining With:

• Percussion and vibration (questionable additional value) 1

Critical Limitations to Acknowledge

The evidence shows that while these techniques increase sputum clearance, their effects on long-term outcomes (quality of life, exacerbation rates, hospitalizations, mortality) remain unknown 1, 8. This means your protocol should focus on short-term, measurable outcomes (secretion clearance, respiratory complication prevention) rather than expecting dramatic changes in overall morbidity and mortality.

The therapy vest specifically has conflicting evidence even in CF patients 1, so its use should be more selective and closely monitored for actual benefit in individual patients.